Does Dr. NACIME SALOMAO BARBACHAN MANSUR have financial conflicts of interest?

Dr. NACIME SALOMAO BARBACHAN MANSUR (MD, PHD) has received a total of $6,025 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $6,025 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. NACIME SALOMAO BARBACHAN MANSUR?

According to CMS Open Payments data, Dr. NACIME SALOMAO BARBACHAN MANSUR received funding from STRYKER CORPORATION ($2,900), MEDSHAPE ($1,603), and EXACTECH ($508).

Does Dr. NACIME SALOMAO BARBACHAN MANSUR receive research grants or speaking fees?

Dr. NACIME SALOMAO BARBACHAN MANSUR has received $6,025 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. NACIME SALOMAO BARBACHAN MANSUR

MD, PHDReal-Time Hydrated

Specialty: Orthopaedic Surgery, Foot and Ankle Surgery

Practice Location: BALTIMORE, MD 21218

NPI Number: 1417679192

LIFETIME INDUSTRY VALUE

$6,025

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BARBACHAN MANSUR is a verified Orthopaedic Surgery, Foot and Ankle Surgery practitioner based in BALTIMORE, MD.

Between 2021 and 2025, Dr. BARBACHAN MANSUR had an overall industry promotional and research financial footprint of $6,025 as recorded in the federal CMS Open Payments database.

$6,025 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BARBACHAN MANSUR's primary funding source is STRYKER CORPORATION, which accounts for $2,900 (representing 48.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

STRYKER CORPORATION

Rank 1

$2,900

48.1%

MEDSHAPE

Rank 2

$1,603

26.6%

EXACTECH

Rank 3

$508

8.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.